Prevalence and Risk Factors of Polymetabolic ovarian Syndrome Among Women of Reproductive Age: A Cross-Sectional Study

Authors

  • Somtochukwu Judith Okafor Department of Medicine, Mater Dei Hospital, Msida, Malta
  • Maheen Furqan Al Huda Medical Center, Multan, Pakistan
  • Nida Waqas Department of Gynaecology and Obstetrics, Khokhar Hospital, Mandi Bahauddin, Pakistan
  • Mentalla ElEmam Hassan ElEmam Dubai Health, Dubai, United Arab Emirates
  • Alaa Tawfig Fatima Jinnah Medical University, Lahore, Pakistan
  • Attiq ur Rehman Shandong First Medical University, Shandong, China
  • Amel Kamil Mohamed Dubai Health, Dubai, United Arab Emirates
  • Shifaa S S Lulu Dubai Health, Dubai, United Arab Emirates
  • Khushboo Kumari People's University of Medical and Health sciences, Nawab Shah, Pakistan

DOI:

https://doi.org/10.65761/jbs.2026.21

Keywords:

Polymetabolic ovarian Syndrome, Metabolic Syndrome, Women of Reproductive Age, Cardiometabolic Risk, Obesity, Lifestyle Factors, Insulin Resistance, Pakistan

Abstract

Background: Polymetabolic ovarian Syndrome represents an important and increasingly recognized cardiometabolic health concern, yet its burden and associated risk factors among women of reproductive age remain insufficiently characterized, particularly within the Pakistani context.

Objective: This study aimed to determine the prevalence of Polymetabolic ovarian Syndrome and identify demographic, reproductive, anthropometric, lifestyle, and clinical factors associated with its occurrence among women of reproductive age.

Methods: A quantitative cross-sectional research design was employed among 423 women aged 18-49 years recruited from selected healthcare facilities and community-based health-screening settings in Punjab, Pakistan. Data were collected using a structured questionnaire, standardized anthropometric and blood-pressure measurements, and fasting venous blood samples for assessment of fasting blood glucose, triglycerides, and high-density lipoprotein cholesterol. The collected data were analyzed using descriptive statistics, chi-square tests, and binary logistic regression to determine prevalence patterns and independent associations.

Results: The findings demonstrated a substantial burden of Polymetabolic ovarian Syndrome among the study population, with greater metabolic vulnerability observed among women of increasing age, higher parity, obesity, central adiposity, inadequate physical activity, unhealthy dietary practices, hypertension, and a family history of diabetes. Individual metabolic abnormalities, including elevated blood pressure, impaired fasting glucose, elevated triglycerides, reduced HDL cholesterol, and central obesity, were also strongly associated with the occurrence of the syndrome.

Implication: These findings highlight the importance of recognizing metabolic risk during the reproductive years, when early identification and lifestyle-based intervention may prevent progression to type 2 diabetes, cardiovascular disease, and other long-term metabolic complications. The study provides clinically relevant evidence for strengthening cardiometabolic screening within women's healthcare services and supports a preventive, life-course approach to women's metabolic health.

References

1. Noubiap JJ, Nansseu JR, Nyaga UF, Ndoadoumgue AL, Ngouo AT, Tounouga DN, et al. Worldwide trends in metabolic syndrome from 2000 to 2023: a systematic review and modelling analysis. Nat Commun. 2025;17(1):573.

2. Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018;20(2):12.

3. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-5.

4. O'Neill S, O'Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev. 2015;16(1):1-12.

5. Rochlani Y, Pothineni NV, Kovelamudi S, Mehta JL. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. Ther Adv Cardiovasc Dis. 2017;11(8):215-25.

6. Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444(7121):881-7.

7. Colpani V, Baena CP, Jaspers L, Van Dijk GM, Farajzadegan Z, Dhana K, et al. Lifestyle factors, cardiovascular disease and all-cause mortality in middle-aged and elderly women: a systematic review and meta-analysis. Eur J Epidemiol. 2018;33(9):831-45.

8. El Khoudary SR, Aggarwal B, Beckie TM, Hodis HN, Johnson AE, Langer RD, et al. Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American Heart Association. Circulation. 2020;142(25):e506-32.

9. Hallajzadeh J, Khoramdad M, Izadi N, Karamzad N, Almasi-Hashiani A, Ayubi E, et al. Metabolic syndrome and its components in premenopausal and postmenopausal women: a comprehensive systematic review and meta-analysis on observational studies. Menopause. 2018;25(10):1155-64.

10. Fjeldstad AS. Effects of resistance training on arterial elasticity and C-reactive protein in premenopausal women [dissertation]. Norman (OK): University of Oklahoma; 2007.

11. García RG, López-Jaramillo P, Mosquera M, Ramírez-Vélez R, Reyes LM. Clinical trial to assess the effect of physical exercise on endothelial function and insulin resistance in pregnant women. Trials. 2009;10:104.

12. Misra A, Khurana L. Obesity-related non-communicable diseases: South Asians vs White Caucasians. Int J Obes. 2011;35(2):167-87.

13. Li Y, Zhao L, Yu D, Wang Z, Ding G. Metabolic syndrome prevalence and its risk factors among adults in China: a nationally representative cross-sectional study. PLoS One. 2018;13(6):e0199293.

14. Karee M, Gundabattula SR, Sashi L, Boorugu H, Chowdhury A. Prevalence of metabolic syndrome in women with polycystic ovary syndrome and the factors associated: a cross-sectional study at a tertiary care center in Hyderabad, south-eastern India. Diabetes Metab Syndr. 2020;14(4):583-7.

15. Luqman MS, Zeba A, Tanveer N, Kareem S. Prevalence of polycystic ovary syndrome (PCOS) and its association with metabolic syndrome in reproductive-aged women: a cross-sectional study. Dev Med Life Sci. 2025;2(5):35-40.

16. Nikpour M, Tirgar A, Hajiahmadi M, Hosseini A, Heidari B, Ghaffari F, et al. Shift work and metabolic syndrome: a multicenter cross-sectional study on females of reproductive age. Biomed Rep. 2019;10(5):311-7.

17. Tabrizi FPF, Alipoor B, Sadaghiani MM, Ostadrahimi A, Mahdavi AM. Metabolic syndrome and its characteristics among reproductive-aged women with polycystic ovary syndrome: a cross-sectional study in Northwest Iran. Int J Fertil Steril. 2013;6(4):244.

18. Chowdhury JJ, Bilkis US, Alam S. Association of pre-pregnancy body mass index and metabolic syndrome with adverse pregnancy outcomes in Bangladeshi women. Barind Med Coll J. 2025;11(2):312-8.

19. Minh HV, Tien HA, Sinh CT, Thang DC, Chen CH, Tay JC, et al. Assessment of preferred methods to measure insulin resistance in Asian patients with hypertension. J Clin Hypertens. 2021;23(3):529-37.

20. Lean ME. Clinical handbook of weight management. Boca Raton: CRC Press; 1998.

21. Gordon JL, Lavoie KL, Arsenault A, Meloche B, Ditto B, Campbell TS, et al. The relationship between multiple health behaviours and brachial artery reactivity. Int J Hypertens. 2012;2012:846819.

22. Thijssen DH, Maiorana AJ, O'Driscoll G, Cable NT, Hopman MT, Green DJ. Impact of inactivity and exercise on the vasculature in humans. Eur J Appl Physiol. 2010;108(5):845-75.

23. Padilla J, Simmons GH, Bender SB, Arce-Esquivel AA, Whyte JJ, Laughlin MH. Vascular effects of exercise: endothelial adaptations beyond active muscle beds. Physiology. 2011;26(3):132-45.

24. Taha M, Sourour DA, Shaker O. Effects of statins on insulin-like growth factor-1 gene expression in fructose induced metabolic syndrome in rats. Open Endocrinol J. 2009;3(1):28-33.

25. McGavock JM. Cardiovascular adaptations to exercise training in older women with and without type 2 diabetes mellitus. 2004.

26. Staszewski J, Dȩbiec A, Skrobowska E, Stȩpień A. Cerebral vasoreactivity changes over time in patients with different clinical manifestations of cerebral small vessel disease. Front Aging Neurosci. 2021;13:727832.

27. Zizek B, Poredos P. Dependence of morphological changes of the carotid arteries on essential hypertension and accompanying risk factors. Int Angiol. 2002;21(1):70.

Published

2026-08-15

Issue

Section

Original Research Article

How to Cite

Judith Okafor, S., Furqan, M., Waqas, N., ElEmam Hassan ElEmam, M., Tawfig, A., Attiq ur Rehman, Kamil Mohamed, A., Shifaa S S Lulu, & Kumari, K. (2026). Prevalence and Risk Factors of Polymetabolic ovarian Syndrome Among Women of Reproductive Age: A Cross-Sectional Study. Journal of Bioscience Studies, 3(2). https://doi.org/10.65761/jbs.2026.21

Share